1 – 10 of 93
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- The potential and perils of observational studies
- Second hit landscape in BRCA1/2-associated breast cancer
- Stromal inflammation, necrosis and HER2 overexpression in ductal carcinoma in situ of the breast : another causality dilemma?
- A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy
- Integrating communication as a core skill in the global curriculum for medical oncology
- 2016
- Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
- 2015
- EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
- Stromal protein expression in breast cancer is differentially regulated by TGF-β1
- Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect
- 2014
- Stromal characteristics are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ (DCIS)